Ito-Kureha, T.* ; Leoni, C.* ; Borland, K.* ; Cantini, G. ; Bataclan, M.* ; Metzger, R.N.* ; Ammann, G.* ; Krug, A.B.* ; Marsico, A. ; Kaiser, S.* ; Canzar, S.* ; Feske, S.* ; Monticelli, S.* ; König, J.* ; Heissmeyer, V.
The function of Wtap in N6-adenosine methylation of mRNAs controls T cell receptor signaling and survival of T cells.
Nat. Immunol. 23, 1208-1221 (2022)
T cell antigen-receptor (TCR) signaling controls the development, activation and survival of T cells by involving several layers and numerous mechanisms of gene regulation. N6-methyladenosine (m6A) is the most prevalent messenger RNA modification affecting splicing, translation and stability of transcripts. In the present study, we describe the Wtap protein as essential for m6A methyltransferase complex function and reveal its crucial role in TCR signaling in mouse T cells. Wtap and m6A methyltransferase functions were required for the differentiation of thymocytes, control of activation-induced death of peripheral T cells and prevention of colitis by enabling gut RORγt+ regulatory T cell function. Transcriptome and epitranscriptomic analyses reveal that m6A modification destabilizes Orai1 and Ripk1 mRNAs. Lack of post-transcriptional repression of the encoded proteins correlated with increased store-operated calcium entry activity and diminished survival of T cells with conditional genetic inactivation of Wtap. These findings uncover how m6A modification impacts on TCR signal transduction and determines activation and survival of T cells.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publication type
Article: Journal article
Document type
Scientific Article
Thesis type
Editors
Keywords
Keywords plus
Language
english
Publication Year
2022
Prepublished in Year
0
HGF-reported in Year
2022
ISSN (print) / ISBN
1529-2908
e-ISSN
1529-2916
ISBN
Book Volume Title
Conference Title
Conference Date
Conference Location
Proceedings Title
Quellenangaben
Volume: 23,
Issue: 8,
Pages: 1208-1221
Article Number: ,
Supplement: ,
Series
Publisher
Nature Publishing Group
Publishing Place
Day of Oral Examination
0000-00-00
Advisor
Referee
Examiner
Topic
University
University place
Faculty
Publication date
0000-00-00
Application date
0000-00-00
Patent owner
Further owners
Application country
Patent priority
Reviewing status
Peer reviewed
POF-Topic(s)
30203 - Molecular Targets and Therapies
30205 - Bioengineering and Digital Health
Research field(s)
Immune Response and Infection
Enabling and Novel Technologies
PSP Element(s)
G-501712-001
G-503800-001
Grants
Deutsche Forschungsgemeinschaft
Copyright
Erfassungsdatum
2022-10-24